CARPENTER TECHNOLOGY CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that CARPENTER TECHNOLOGY CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Jun 30, 2018 | $618.00M | Aug 14, 2018 |
| FY2018 | Mar 31, 2018 | $572.20M | Aug 14, 2018 |
| FY2018 | Dec 31, 2017 | $487.80M | Aug 14, 2018 |
| FY2018 | Sep 30, 2017 | $479.80M | Aug 14, 2018 |
| FY2018 | Jun 30, 2017 | $507.70M | Aug 14, 2018 |
| FY2018 | Mar 31, 2017 | $473.60M | Aug 14, 2018 |
| FY2018 | Dec 31, 2016 | $427.40M | Aug 14, 2018 |
| FY2018 | Sep 30, 2016 | $389.00M | Aug 14, 2018 |
| FY2018 | Jun 30, 2016 | $1.81B | Aug 14, 2018 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $2.88B | Aug 12, 2025 |
| FY2025 | Jun 30, 2024 | $2.76B | Aug 12, 2025 |
| FY2023 | Jun 30, 2023 | $1.84B | Aug 11, 2023 |
| FY2024 | Jun 30, 2022 | $1.84B | Aug 13, 2024 |
| FY2023 | Jun 30, 2021 | $1.48B | Aug 11, 2023 |
| FY2020 | Jun 30, 2020 | $437.30M | Sep 4, 2020 |
| FY2020 | Mar 31, 2020 | $585.40M | Sep 4, 2020 |
| FY2020 | Dec 31, 2019 | $573.00M | Sep 4, 2020 |
| FY2020 | Sep 30, 2019 | $585.40M | Sep 4, 2020 |
| FY2020 | Jun 30, 2019 | $641.40M | Sep 4, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Jun 30, 2017 | $507.70M | Aug 11, 2017 |
| FY2017 | Mar 31, 2017 | $473.60M | Aug 11, 2017 |
| FY2017 | Dec 31, 2016 | $427.40M | Aug 11, 2017 |
| FY2017 | Sep 30, 2016 | $389.00M | Aug 11, 2017 |
| FY2017 | Jun 30, 2016 | $457.70M | Aug 11, 2017 |
| FY2017 | Mar 31, 2016 | $456.30M | Aug 11, 2017 |
| FY2017 | Dec 31, 2015 | $443.80M | Aug 11, 2017 |
| FY2017 | Sep 30, 2015 | $455.60M | Aug 11, 2017 |
| FY2016 | Jun 30, 2015 | $558.00M | Aug 18, 2016 |
| FY2016 | Mar 31, 2015 | $570.60M | Aug 18, 2016 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $768.60M | Aug 12, 2025 |
| FY2025 | Jun 30, 2024 | $584.30M | Aug 12, 2025 |
| FY2025 | Jun 30, 2023 | $337.30M | Aug 12, 2025 |
| FY2024 | Jun 30, 2022 | $149.80M | Aug 13, 2024 |
| FY2023 | Jun 30, 2021 | $1.00M | Aug 11, 2023 |
| FY2020 | Jun 30, 2020 | ($5.30M) | Sep 4, 2020 |
| FY2020 | Mar 31, 2020 | $109.50M | Sep 4, 2020 |
| FY2020 | Dec 31, 2019 | $112.60M | Sep 4, 2020 |
| FY2020 | Sep 30, 2019 | $112.60M | Sep 4, 2020 |
| FY2020 | Jun 30, 2019 | $122.90M | Sep 4, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $376.00M | Aug 12, 2025 |
| FY2025 | Jun 30, 2024 | $186.50M | Aug 12, 2025 |
| FY2025 | Jun 30, 2023 | $56.40M | Aug 12, 2025 |
| FY2024 | Jun 30, 2022 | ($49.10M) | Aug 13, 2024 |
| FY2023 | Jun 30, 2021 | ($229.60M) | Aug 11, 2023 |
| FY2020 | Jun 30, 2020 | ($118.40M) | Sep 4, 2020 |
| FY2020 | Mar 31, 2020 | $39.90M | Sep 4, 2020 |
| FY2020 | Dec 31, 2019 | $38.80M | Sep 4, 2020 |
| FY2020 | Sep 30, 2019 | $41.20M | Sep 4, 2020 |
| FY2020 | Jun 30, 2019 | $48.90M | Sep 4, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $521.80M | Aug 12, 2025 |
| FY2025 | Jun 30, 2024 | $323.10M | Aug 12, 2025 |
| FY2025 | Jun 30, 2023 | $133.10M | Aug 12, 2025 |
| FY2024 | Jun 30, 2022 | ($24.90M) | Aug 13, 2024 |
| FY2023 | Jun 30, 2021 | ($248.60M) | Aug 11, 2023 |
| FY2020 | Jun 30, 2020 | ($148.20M) | Sep 4, 2020 |
| FY2020 | Mar 31, 2020 | $58.70M | Sep 4, 2020 |
| FY2020 | Dec 31, 2019 | $55.00M | Sep 4, 2020 |
| FY2020 | Sep 30, 2019 | $59.80M | Sep 4, 2020 |
| FY2020 | Jun 30, 2019 | $67.90M | Sep 4, 2020 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $26.10M | Aug 12, 2025 |
| FY2025 | Jun 30, 2024 | $25.60M | Aug 12, 2025 |
| FY2025 | Jun 30, 2023 | $24.40M | Aug 12, 2025 |
| FY2024 | Jun 30, 2022 | $20.40M | Aug 13, 2024 |
| FY2023 | Jun 30, 2021 | $19.70M | Aug 11, 2023 |
| FY2022 | Jun 30, 2020 | $28.00M | Aug 15, 2022 |
| FY2021 | Jun 30, 2019 | $23.30M | Aug 19, 2021 |
| FY2020 | Jun 30, 2018 | $19.30M | Sep 4, 2020 |
| FY2019 | Jun 30, 2017 | $16.90M | Aug 29, 2019 |
| FY2018 | Jun 30, 2016 | $16.30M | Aug 14, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $243.20M | Aug 12, 2025 |
| FY2025 | Jun 30, 2024 | $230.20M | Aug 12, 2025 |
| FY2025 | Jun 30, 2023 | $204.20M | Aug 12, 2025 |
| FY2024 | Jun 30, 2022 | $174.70M | Aug 13, 2024 |
| FY2023 | Jun 30, 2021 | $180.20M | Aug 11, 2023 |
| FY2022 | Jun 30, 2020 | $201.00M | Aug 15, 2022 |
| FY2021 | Jun 30, 2019 | $203.40M | Aug 19, 2021 |
| FY2020 | Jun 30, 2018 | $193.00M | Sep 4, 2020 |
| FY2019 | Jun 30, 2017 | $176.10M | Aug 29, 2019 |
| FY2018 | Jun 30, 2016 | $173.80M | Aug 14, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $440.40M | Aug 12, 2025 |
| FY2025 | Jun 30, 2024 | $274.90M | Aug 12, 2025 |
| FY2025 | Jun 30, 2023 | $14.70M | Aug 12, 2025 |
| FY2024 | Jun 30, 2022 | $6.00M | Aug 13, 2024 |
| FY2023 | Jun 30, 2021 | $250.00M | Aug 11, 2023 |
| FY2022 | Jun 30, 2020 | $231.80M | Aug 15, 2022 |
| FY2021 | Jun 30, 2019 | $232.40M | Aug 19, 2021 |
| FY2020 | Jun 30, 2018 | $209.20M | Sep 4, 2020 |
| FY2019 | Jun 30, 2017 | $130.30M | Aug 29, 2019 |
| FY2018 | Jun 30, 2016 | $257.40M | Aug 14, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $3.49B | Aug 12, 2025 |
| FY2025 | Jun 30, 2024 | $3.29B | Aug 12, 2025 |
| FY2024 | Jun 30, 2023 | $3.05B | Aug 13, 2024 |
| FY2023 | Jun 30, 2022 | $2.93B | Aug 11, 2023 |
| FY2022 | Jun 30, 2021 | $2.97B | Aug 15, 2022 |
| FY2021 | Jun 30, 2020 | $3.23B | Aug 19, 2021 |
| FY2020 | Jun 30, 2019 | $3.19B | Sep 4, 2020 |
| FY2019 | Jun 30, 2018 | $3.01B | Aug 29, 2019 |
| FY2018 | Jun 30, 2017 | $2.88B | Aug 14, 2018 |
| FY2017 | Jun 30, 2016 | $2.79B | Aug 11, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $1.60B | Aug 12, 2025 |
| FY2025 | Jun 30, 2024 | $1.66B | Aug 12, 2025 |
| FY2024 | Jun 30, 2023 | $1.66B | Aug 13, 2024 |
| FY2023 | Jun 30, 2022 | $1.60B | Aug 11, 2023 |
| FY2022 | Jun 30, 2021 | $1.58B | Aug 15, 2022 |
| FY2021 | Jun 30, 2020 | $1.78B | Aug 19, 2021 |
| FY2020 | Jun 30, 2019 | $1.67B | Sep 4, 2020 |
| FY2019 | Jun 30, 2018 | $1.52B | Aug 29, 2019 |
| FY2018 | Jun 30, 2017 | $1.68B | Aug 14, 2018 |
| FY2017 | Jun 30, 2016 | $1.69B | Aug 11, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $1.89B | Aug 12, 2025 |
| FY2025 | Jun 30, 2024 | $1.63B | Aug 12, 2025 |
| FY2025 | Jun 30, 2023 | $1.40B | Aug 12, 2025 |
| FY2025 | Jun 30, 2022 | $1.33B | Aug 12, 2025 |
| FY2024 | Jun 30, 2021 | $1.39B | Aug 13, 2024 |
| FY2023 | Jun 30, 2020 | $1.45B | Aug 11, 2023 |
| FY2022 | Jun 30, 2019 | $1.52B | Aug 15, 2022 |
| FY2021 | Jun 30, 2018 | $1.49B | Aug 19, 2021 |
| FY2020 | Jun 30, 2017 | $1.20B | Sep 4, 2020 |
| FY2017 | Jun 30, 2016 | $1.10B | Aug 11, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $227.30M | Aug 12, 2025 |
| FY2025 | Jun 30, 2024 | $227.30M | Aug 12, 2025 |
| FY2025 | Jun 30, 2023 | $241.40M | Aug 12, 2025 |
| FY2024 | Jun 30, 2022 | $241.40M | Aug 13, 2024 |
| FY2023 | Jun 30, 2021 | $241.40M | Aug 11, 2023 |
| FY2022 | Jun 30, 2020 | $290.40M | Aug 15, 2022 |
| FY2021 | Jun 30, 2019 | $326.40M | Aug 19, 2021 |
| FY2020 | Jun 30, 2018 | $268.70M | Sep 4, 2020 |
| FY2019 | Jun 30, 2017 | $263.40M | Aug 29, 2019 |
| FY2018 | Jun 30, 2016 | $244.80M | Aug 14, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $1.71B | Aug 12, 2025 |
| FY2025 | Jun 30, 2024 | $1.37B | Aug 12, 2025 |
| FY2024 | Jun 30, 2023 | $1.23B | Aug 13, 2024 |
| FY2023 | Jun 30, 2022 | $1.21B | Aug 11, 2023 |
| FY2022 | Jun 30, 2021 | $1.30B | Aug 15, 2022 |
| FY2021 | Jun 30, 2020 | $1.57B | Aug 19, 2021 |
| FY2020 | Jun 30, 2019 | $1.61B | Sep 4, 2020 |
| FY2019 | Jun 30, 2018 | $1.48B | Aug 29, 2019 |
| FY2018 | Jun 30, 2017 | $1.32B | Aug 14, 2018 |
| FY2017 | Jun 30, 2016 | $1.31B | Aug 11, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $315.50M | Aug 12, 2025 |
| FY2025 | Jun 30, 2024 | $199.10M | Aug 12, 2025 |
| FY2024 | Jun 30, 2023 | $44.50M | Aug 13, 2024 |
| FY2023 | Jun 30, 2022 | $154.20M | Aug 11, 2023 |
| FY2022 | Jun 30, 2021 | $287.40M | Aug 15, 2022 |
| FY2021 | Jun 30, 2020 | $193.10M | Aug 19, 2021 |
| FY2020 | Jun 30, 2019 | $27.00M | Sep 4, 2020 |
| FY2019 | Jun 30, 2018 | $56.20M | Aug 29, 2019 |
| FY2018 | Jun 30, 2017 | $66.30M | Aug 14, 2018 |
| FY2018 | Jun 30, 2016 | $82.00M | Aug 14, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Jun 30, 2019 | $550.60M | Aug 29, 2019 |
| FY2019 | Jun 30, 2018 | $545.70M | Aug 29, 2019 |
| FY2018 | Jun 30, 2017 | $605.00M | Aug 14, 2018 |
| FY2017 | Jun 30, 2016 | $611.30M | Aug 11, 2017 |
| FY2016 | Jun 30, 2015 | $603.80M | Aug 18, 2016 |
| FY2015 | Jun 30, 2014 | $604.30M | Aug 25, 2015 |
| FY2014 | Jun 30, 2013 | $604.20M | Aug 26, 2014 |
| FY2013 | Jun 30, 2012 | $406.90M | Aug 23, 2013 |
| FY2012 | Jun 30, 2011 | $507.80M | Aug 22, 2012 |
| FY2011 | Jun 30, 2010 | $259.60M | Aug 24, 2011 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 7 | Aug 12, 2025 |
| FY2025 | Jun 30, 2024 | 3 | Aug 12, 2025 |
| FY2025 | Jun 30, 2023 | 1 | Aug 12, 2025 |
| FY2024 | Jun 30, 2022 | (1) | Aug 13, 2024 |
| FY2023 | Jun 30, 2021 | (4) | Aug 11, 2023 |
| FY2020 | Jun 30, 2020 | (2) | Sep 4, 2020 |
| FY2020 | Mar 31, 2020 | 0 | Sep 4, 2020 |
| FY2020 | Dec 31, 2019 | 0 | Sep 4, 2020 |
| FY2020 | Sep 30, 2019 | 0 | Sep 4, 2020 |
| FY2020 | Jun 30, 2019 | 1 | Sep 4, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 7 | Aug 12, 2025 |
| FY2025 | Jun 30, 2024 | 3 | Aug 12, 2025 |
| FY2025 | Jun 30, 2023 | 1 | Aug 12, 2025 |
| FY2024 | Jun 30, 2022 | (1) | Aug 13, 2024 |
| FY2023 | Jun 30, 2021 | (4) | Aug 11, 2023 |
| FY2020 | Jun 30, 2020 | (2) | Sep 4, 2020 |
| FY2020 | Mar 31, 2020 | 0 | Sep 4, 2020 |
| FY2020 | Dec 31, 2019 | 0 | Sep 4, 2020 |
| FY2020 | Sep 30, 2019 | 0 | Sep 4, 2020 |
| FY2020 | Jun 30, 2019 | 1 | Sep 4, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 49.71M | Aug 12, 2025 |
| FY2025 | Jun 30, 2024 | 49.78M | Aug 12, 2025 |
| FY2025 | Jun 30, 2023 | 48.64M | Aug 12, 2025 |
| FY2025 | Jun 30, 2022 | 48.29M | Aug 12, 2025 |
| FY2024 | Jun 30, 2021 | 48.04M | Aug 13, 2024 |
| FY2023 | Jun 30, 2020 | 47.85M | Aug 11, 2023 |
| FY2022 | Jun 30, 2019 | 47.47M | Aug 15, 2022 |
| FY2021 | Jun 30, 2018 | 47.19M | Aug 19, 2021 |
| FY2020 | Jun 30, 2017 | 46.75M | Sep 4, 2020 |
| FY2019 | Jun 30, 2016 | 46.60M | Aug 29, 2019 |